Director sold ~$228K of ResMed|
Scheduled in advanceLoading…
Stake as of Jun 30, 2026 · Filed Aug 7, 2026
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
Undefined
Compared with the manager's prior 13F
—
NaN
For the same quarter
Director sold ~$228K of ResMed|
Scheduled in advanceDirector plans to sell ~$228K of ResMed|
Planned, from payFrom a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
